We are thrilled to announce the installation of our new NMR (Nuclear Magnetic Resonance) equipment at our research facility in Tunisia. This marks the first time such advanced analytical technology has been introduced to Tunisia by a private-sector entity.
The acquisition of this long-awaited equipment will represent a significant milestone for NovAliX, greatly enhancing our synthetic chemistry capabilities. With this investment, we anticipate a range of benefits, including:
- Provision of more comprehensive results
- Enhanced reactivity leading to reduced delivery times
- Cost reduction
Indeed, transitioning from outsourced to insourced services thanks to this NMR instrument equipped with an autosampler, will enable faster validation of results, thereby shortening the time dedicated to a given synthesis. This will significantly impact the delivery times of final products to our clients, while also increasing the number of projects possible to support.
For Hajer Abdelkafi, PhD, Site Director at our Tunisian site: “this major investment represents the culmination of several years of work and confirms NovAliX’s presence in Tunisia. The newly installed NMR machine further expands our analytical platform”.
More about AvanceCore 400 MHz NMR
Xavier Girod, Analytics Manager at NovAliX, explains:
“For us, the AvanceCore 400 MHz NMR is an indispensable tool in drug development, providing user-friendly automation for timely analytical results. With superior data quality and a range of automated experiments, it boosts productivity for large groups of users. Its affordability, resiliency, and ample capacity meet growing analytical demands without further investments. We are delighted with our choice of the AvanceCore.”
Our gratitude goes to our partners Bruker and Evosciences for their invaluable support in deploying the AvanceCore at our Tunisian facility. Indeed, Bruker’s high performance instrument will enable our scientists to explore life and materials at molecular, cellular, and microscopic levels.